/C O R R E C T I O N -- AbbVie/
/C O R R E C T I O N -- AbbVie/ |
| [31-March-2026] |
In the news release, Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®, issued 31-Mar-2026 by AbbVie over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®
IRVINE, Calif., March 31, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced its fourth annual CoolMonth, featuring exclusive offers on CoolSculpting®, the treatment doctors use most for nonsurgical fat reduction.1
Spring is often thought of as a transformative season, making the return of CoolMonth this April a perfect opportunity to reprioritize aesthetic goals. In fact, 50% of people reportedly have considered body contouring treatments (invasive and noninvasive) in preparation for summer.2‡ CoolSculpting® can permanently eliminate treated fat without surgery and with little to no downtime.3,4 It is an FDA-cleared product proven to contour the body by freezing away stubborn fat.5 "By establishing this meaningful annual moment, we're not only translating interest into action—we're building trust and advancing education," said Glen Curran, Senior Vice President Allergan Aesthetics. "Whether patients are experiencing body changes following weight loss with GLP-1 medication, noticing specific areas resistant to diet and exercise, or simply seeking a more sculpted appearance, CoolMonth helps them take the next step toward achieving their goals." Follow these steps to access CoolMonth offers:
"The spring is a great time to begin a personalized CoolSculpting® treatment plan so you can start seeing results in time for warmer weather," said Melissa Mickelson, Co-Founder Bodify and Master Certified CoolSculpting® Expert. Jessica Stellwagen, Co-Founder Bodify and Master Certified CoolSculpting® Expert, continued saying, "During each consultation, we evaluate whether a patient is a good candidate, discuss their body contouring goals, and create a customized approach to help achieve their desired look. If you've been considering body contouring, CoolMonth is the perfect time to take advantage of this special offer and book your consultation." CoolSculpting® and CoolSculpting® Elite are FDA-cleared for the treatment of visible fat bulges in the submental (under the chin) and submandibular (under the jawline) areas, thigh, abdomen, and flank, along with bra fat, back fat, underneath the buttocks (also known as banana roll), and upper arm. It is also FDA-cleared to affect the appearance of lax tissue with submental area treatments. CoolSculpting® and CoolSculpting® Elite are not treatments for weight loss. To learn more about CoolSculpting® and CoolSculpting® Elite, the CoolMonth offerings and to find a provider near you, please visit www.CoolSculpting.com. *NO PURCHASE NECESSARY. Open to Allē Members in 50 U.S./D.C.; 18+ (19+ in AL, NE; 21+ in MS). You must register online at https://coolscul.pt/new-patients between 12:00:01 AM PT on 4/1/26 and 11:59:59 PM PT on 4/30/26. See full Official Rules for all details and how to enter without purchase at https://coolscul.pt/new-patients. †Offers are for a limited time only and while supplies last. Terms and Conditions apply. Limited Member eligibility applies. ‡Online survey conducted in 2023 of consumers aged between 25 to 55 with a household income of > $75,000 (N= 200 consumers aware of and interested in receiving body contouring within the next year) About Allergan Aesthetics About AbbVie Forward-Looking Statements CoolSculpting® and CoolSculpting® Elite Uses and Important Safety Information Uses CoolSculpting® and CoolSculpting® Elite are FDA-cleared for the treatment of visible fat bulges in the submental (under the chin) and submandibular (under the jawline) areas, thigh, abdomen, and flank, along with bra fat, back fat, underneath the buttocks (also known as banana roll), and upper arm. It is also FDA-cleared to affect the appearance of lax tissue with submental area treatments. CoolSculpting® and CoolSculpting® Elite are not treatments for weight loss. Important Safety Information This procedure is not for everyone. You should not be treated with CoolSculpting® or CoolSculpting® Elite if you suffer from cryoglobulinemia, cold agglutinin disease, or paroxysmal cold hemoglobinuria. Tell your doctor if you are pregnant or have any medical conditions including recent surgery, pre-existing hernia, and any known sensitivities or allergies. During the procedure you may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching, cramping and discomfort at the treatment site. These sensations lessen as the area becomes numb. Following the procedure, typical side effects include temporary redness, swelling, blanching, bruising, firmness, stinging, tenderness, cramping, skin inflammation and aching. Sensory alteration (itching, skin sensitivity, tingling, and numbness) can persist up to several weeks after treatment. You may also experience throat discomfort/soreness and sensation of fullness in the back of the throat after submental or submandibular area treatment. Rare side effects may happen in 1 to 10 out of 10,000 CoolSculpting® and CoolSculpting® Elite treatments (between 0.01% to 0.1%). One such rare side effect is a visible enlargement in the treated area, which may develop 2 to 5 months after treatment, will not resolve on its own, and may require surgical intervention for correction. Please see full Important Safety Information for CoolSculpting® and CoolSculpting® Elite on CoolSculpting.com. REFERENCES:
Investors: Correction: Links in the *NO PURCHASE NECESSARY. paragraph have been updated from an earlier version of this release.
SOURCE AbbVie | ||
Company Codes: NYSE:ABBV |
View original content to download multimedia:
